5
|
Trovato M, Villari D, Ruggeri RM, Quattrocchi E, Fragetta F, Simone A, Scarfi R, Magro G, Batolo D, Trimarchi F, Benvenga S. Expression of CD30 ligand and CD30 receptor in normal thyroid and benign and malignant thyroid nodules. Thyroid 2001; 11:621-8. [PMID: 11484890 DOI: 10.1089/105072501750362682] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
Because the CD30 ligand (CD30L)/CD30 receptor (CD30) system is expressed in certain malignancies, but has not been studied in thyroid nodules, we investigated its immunohistochemical expression in 6 normal thyroids (NT) and 131 thyroid nodules: 28 colloid nodules (CN), 45 adenomas (15 oncocytic [OA], 30 follicular [FA]) and 58 carcinomas (15 follicular [FTC], 1 insular [ITC], 6 anaplastic [ATC], 30 papillary [PTC], and 6 medullary [MTC]). NT and CN expressed neither CD30L nor CD30 (CD30L-/CD30-). Forty percent of OA and 20% of FA showed epithelial coexpression of CD30L and CD30, and interstitial expression of CD30L, which was also observed in the surrounding normal tissue. Within malignancies, epithelial coexpression of CD30L and CD30 was observed in 7% of FTC, 33% of ATC, 67% of PTC, and 67% of MTC. Only PTC and MTC showed epithelial expression of CD30L in the perinodular tissue with similar frequency (80% PTC, 75% MTC). PTC and MTC had the highest proportion of CD30L+ or CD30+ cells, and together with OA, a thus far unreported nuclear location of CD30L. In PTC, the proportion of CD30L+ cells and the prevalence of nuclear location of CD30L correlated inversely and directly, respectively, with aggressiveness. In conclusion, CD30L/CD30 signaling is activated only past the colloid nodule stage, most frequently in an autocrine fashion.
Collapse
Affiliation(s)
- M Trovato
- Dipartimento di Patologia Umana, University of Messina, School of Medicine, Italy
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
6
|
Quattrocchi E, Dallman MJ, Dhillon AP, Quaglia A, Bagnato G, Feldmann M. Murine IL-10 gene transfer inhibits established collagen-induced arthritis and reduces adenovirus-mediated inflammatory responses in mouse liver. J Immunol 2001; 166:5970-8. [PMID: 11342612 DOI: 10.4049/jimmunol.166.10.5970] [Citation(s) in RCA: 34] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
The effects of homologous IL-10 administration during an established autoimmune disease are controversial, given its reported immunostimulatory and immunosuppressive properties. Studies of collagen-induced arthritis have shown efficacy with repeated administrations of IL-10; however, when the EBV IL-10 homologue was administered via adenovirus gene transfer technology the results were equivocal. Therefore, the present study was undertaken to elucidate the effects of prolonged homologous IL-10 administration via adenovirus-mediated gene delivery on the progression of established arthritis. Collagen type II (CII)-immunized mice received i.v. injections of 10(7) or 10(8) PFU of an E1-deleted adenoviral vector containing the murine IL-10 gene (AdIL-10), after arthritis onset. Mice were monitored for 3 wk for disease progression, and gene transduction was assessed by quantification of serum mIL-10. CII-specific cell-mediated and humoral immune responses were analyzed by lymph node cell proliferation, cytokine production, and anti-CII Ab responses. Furthermore, because adenoviral vectors have been reported to induce organ dysfunction due to cell-mediated immune responses to the viral Ags, we have also evaluated delayed-type hypersensitivity responses and reactive hepatitis to the systemically delivered adenovirus and whether the IL-10 produced could influence those responses. Sustained suppression of autoimmune arthritis and elevated serum levels of IL-10 were achieved in our study. AdIL-10 treatment reduced cell-mediated immune reactivity, but did not affect humoral responses. Furthermore, IL-10 was able to reduce, but not totally abrogate, adenovirus-induced hepatic inflammation. These findings provide further insights into the diverse interplay of immune processes involved in autoimmune inflammation and the mechanism of cytokine immunotherapy.
Collapse
MESH Headings
- Adenoviruses, Human/genetics
- Adenoviruses, Human/immunology
- Animals
- Anti-Inflammatory Agents, Non-Steroidal/administration & dosage
- Arthritis, Experimental/genetics
- Arthritis, Experimental/immunology
- Arthritis, Experimental/prevention & control
- Collagen/antagonists & inhibitors
- Epitopes, T-Lymphocyte/immunology
- Genetic Vectors/administration & dosage
- Genetic Vectors/immunology
- Hindlimb
- Humans
- Hypersensitivity, Delayed/immunology
- Hypersensitivity, Delayed/pathology
- Hypersensitivity, Delayed/virology
- Immunoglobulin G/biosynthesis
- Immunoglobulin G/blood
- Immunosuppressive Agents/administration & dosage
- Injections, Intraperitoneal
- Injections, Intravenous
- Injections, Subcutaneous
- Interleukin-10/administration & dosage
- Interleukin-10/genetics
- Liver/immunology
- Liver/pathology
- Liver/virology
- Lymphocyte Activation/genetics
- Male
- Mice
- Mice, Inbred DBA
- T-Lymphocytes/immunology
- Transduction, Genetic
Collapse
Affiliation(s)
- E Quattrocchi
- Kennedy Institute of Rheumatology Division, Imperial College School of Medicine, Hammersmith, London, United Kingdom
| | | | | | | | | | | |
Collapse
|
8
|
Quattrocchi E, Dallman MJ, Feldmann M. Adenovirus-mediated gene transfer of CTLA-4Ig fusion protein in the suppression of experimental autoimmune arthritis. Arthritis Rheum 2000. [PMID: 10943858 DOI: 10.1002/1529-0131(200008)43:8<1688::aid-anr4>3.0.co;2-c] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 01/21/2023]
Abstract
OBJECTIVE Blockade of CD28-B7 interactions with soluble CTLA-4Ig fusion protein (which binds and blocks both B7-1 and B7-2 costimulatory molecules on antigen-presenting cells) has been shown to ameliorate experimental autoimmune diseases such as lupus, experimental autoimmune encephalomyelitis, diabetes, and, in our laboratory, collagen-induced arthritis (CIA). Because prolonged inhibition of this costimulatory pathway may be required, and the adenovirus-mediated gene-transfer technology is very efficient in achieving sustained expression of proteins in vivo, we examined the effects of adenovirally delivered CTLA-4Ig in established murine CIA. METHOD Replication-deficient recombinant adenoviruses encoding a chimeric CTLA-4Ig fusion protein, or beta-galactosidase as control, were injected intravenously into male DBA/1 mice once at arthritis onset. Disease activity was monitored by the assessment of clinical score, paw thickness, and type II collagen (CII)-specific cellular and humoral responses for 3 weeks. Groups of mice were also serially injected with a CTLA-4Ig fusion protein and an anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) monoclonal antibody (mAb), and disease activity was compared with that in the adenovirally transfused groups. RESULTS Both the adenovirally delivered and the recombinant CTLA-4Ig fusion protein suppressed established CIA, whereas anti-CTLA-4 mAb and the control beta-galactosidase adenovirus did not significantly affect the disease course. CII-specific lymphocyte proliferation, interferon-gamma production, and anti-CII antibody levels, both IgG1 and IgG2a, were significantly reduced by CTLA-4Ig treatment. CONCLUSION Blockade of the B7-CD28 costimulatory pathway by adenovirus-mediated CTLA-4Ig gene transfer is as effective as the recombinant fusion protein in treating established CIA, without the need for repeated administrations. Significant reduction in pathogenic cellular and humoral responses is achieved even after the onset of arthritis, thus suggesting the valuable therapeutic potential of this gene-transfer method in human rheumatoid arthritis.
Collapse
Affiliation(s)
- E Quattrocchi
- Imperial College of Science, Technology and Medicine, London, UK
| | | | | |
Collapse
|
15
|
Aruin LI, Sarkisov DS, Lisenco OA, O’Connor H, Cunnane K, Queiroz DMM, Mendes EN, Rocha GA, Moura SB, Resende LMH, Cunha-Melo JR, Carvalho AST, Coelho LGV, Passos MCG, Castro LP, Oliveira CA, Lima GF, Barbosa AJA, Passos MCF, Castro P, Testino G, Perasso A, Boixeda D, de Argila CM, Vila T, Redondo C, Cantón R, Avila C, Alvarez-Baleriola I, de Rafael L, Witteman EM, Becx MCJM, De Koning RW, Silva JCP, Nogueira AMMF, Paulino E, Miranda CR, Rudelli A, Vialette G, Sevestre H, Capron D, Ducroix JP, Smail A, Baillet J, Zerbib F, Seurat PL, Sauvet P, Bechade D, Rapp N, Peacock JS, Marchildon P, Zamaniyan F, Bond-Green J, Liu P, Ciota L, Lee A, Coltro N, Chen M, Alhomsi M, Adeyemi E, Goodwin CS, Rizzi C, Maieron R, Desinan L, Avellini C, Da Broi GL, Beltrami CA, Proto G, Grimaldi F, Proietti A, Scott CA, Takasashi S, Igarshi H, Ishiyama N, Nakamura K, Masubuchi N, Ozaki M, Saito S, Aoyagi T, Itoh T, Hirata I, Matysiak-Budnik T, Poniewierka E, Gasciniak G, Jelen M, Knapik Z, Gosciniak G, Neri WM, Susi D, Bovani I, Laterza F, Cuccurullo F, Amorosi A, Bechi P, Dei R, Mazzanti R, Lynch DAF, Sobala GM, Gledhill A, Jackson P, Crabtree JE, Foster PN, Axon ATR, Dixon MF, Maaroos HI, Sipponen P, Kekki M, Di Bello MG, Raspanti S, Vardar T, Sancho FJ, Olivia E, Saiz S, Mones JP, Hood C, Lesna M, Alcolado R, Knitht T, Greaves S, Wilson A, Corlett M, Webb P, Wyatt J, Newell D, Hengels K, Forman D, Elder JB, Farinati F, Cardin R, Valiante F, Libera GD, Plebani M, Rugge M, Baffa R, Guido M, Mario FD, Naccarato R, Gilvarry J, Leen E, Sant S, Sweeney E, Morain CO, Schönlebe J, Riedel H, Prinz M, Hahn L, Porst H, Lohmann H, Orsini E, Guerre J, Tulliez M, Chaussade S, Gaudric M, Canton R, Sampedro J, García-Plaza A, Cognein P, Parodi MC, Tucci A, Gasperoni S, Stanghellini V, Tosetti C, Paparo GF, Varoli O, Siringo S, Santucci R, Monetti N, Barbara G, Corinaldesi R, Di Mario F, Dotto P, Vianello F, M. F, Grasso GA, Bianco TD, Laino G, Germanà B, Battaglia G, Axelson CK, Andersen LP, Szecsi PB, Olsen KN, Lundborg CJ, Andre C, Descos L, Martin A, Cavagna S, Brassens-Rabbé MP, Wu S, Wadström T, Mégraud F, Perdichizzi G, Muratori L, Pallio S, Bottair M, T. Fera M, Quattrocchi E, Caruso V, Karttunen T, Kerola T, Kartttunen R, Niemelä S, Kosunen TU, Bonchviam F, Pretolani S, Baraldine M, Cilla D, Baldinelli S, Gasparrini G. Pathology. Ir J Med Sci 1992. [DOI: 10.1007/bf02942888] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|